Characterisation of multiple sclerosis pathology by “ultra small parti
Characterisation of multiple sclerosis pathology by “ultra small particles of iron oxide (USPIO)” in comparison with conventional and advanced MRI imaging techniques
What it found
We found no results in the registry or in papers.
What was tested
Treatment tested
- "SH U 555 C"
What it measured
Main measures
1. USPIO enhancement pattern in cerebral and cervical MRI
MRI lesions
Who could take part
Early (CIS/RIS)
Show the full criteria
Inclusion criteria
Inclusion: a. clinically definite MS acc. to McDonald's criteria for the MS group (N=90) Exclusion: a. Age below 18 years
Exclusion criteria
Not separately supplied in the registry.
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
To define magnetic resonance imaging enhancement patterns in patients with multiple sclerosis (MS) and clinically isolated syndrome (CIS). Subgroups of patients with and without gadolinium enhancement and patients with and without immunomodulatory therapy are compared.
Loading reviews and guidelines…
History
- Status changed from Ongoing to Status unknown
- Result signal changed from Ongoing to Status unknown
Started
Mar 2007